KRT17 Gene Steatocystoma Multiplex NGS Genetic DNA Test
Comprehensive Genetic Analysis for Skin Cyst Disorders
The KRT17 Gene Steatocystoma Multiplex NGS Genetic DNA Test represents a breakthrough in dermatological genetic testing, specifically designed to identify mutations in the KRT17 gene associated with steatocystoma multiplex. This rare autosomal dominant disorder manifests as multiple sebaceous cysts typically appearing during adolescence or early adulthood. Our advanced Next-Generation Sequencing technology provides unparalleled accuracy in detecting genetic variations, enabling precise diagnosis and personalized treatment strategies.
What This Test Measures and Detects
This sophisticated genetic analysis specifically targets the KRT17 gene, which encodes keratin 17—a crucial structural protein in epithelial cells. The test identifies:
- Pathogenic variants in the KRT17 gene sequence
- Single nucleotide polymorphisms (SNPs) associated with steatocystoma multiplex
- Insertion and deletion mutations affecting keratin production
- Genetic markers indicating autosomal dominant inheritance patterns
- Specific mutations linked to cyst formation and development
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Multiple sebaceous cysts appearing during adolescence or early adulthood
- Family history of steatocystoma multiplex or similar skin disorders
- Recurrent cyst formation requiring frequent medical intervention
- Unexplained skin lesions with sebaceous characteristics
- Planning for family and wanting to understand genetic inheritance risks
- Diagnostic uncertainty regarding multiple cutaneous cysts
Significant Benefits of Genetic Testing
Undergoing the KRT17 genetic test provides numerous advantages:
- Accurate Diagnosis: Confirms steatocystoma multiplex with genetic certainty
- Personalized Treatment: Enables targeted therapeutic approaches
- Family Planning: Provides crucial information for genetic counseling
- Early Intervention: Facilitates proactive management strategies
- Peace of Mind: Eliminates diagnostic uncertainty and anxiety
- Comprehensive Care: Integrates dermatological and genetic perspectives
Understanding Your Test Results
Our comprehensive genetic report provides clear, actionable information:
- Positive Result: Indicates presence of KRT17 gene mutation, confirming steatocystoma multiplex diagnosis
- Negative Result: Suggests absence of tested mutations, though clinical evaluation remains important
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Determines inheritance patterns for family planning purposes
All results include detailed interpretation by our genetic specialists and recommendations for next steps in management.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Control of Your Genetic Health Today
Don’t let uncertainty about your skin condition affect your quality of life. The KRT17 Gene Steatocystoma Multiplex NGS Genetic DNA Test provides the clarity you need for effective management and peace of mind. Our genetic counselors are available to discuss your results and provide personalized guidance.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and achieving better dermatological outcomes.
